搜索临床试验以:血管紧张素转换酶抑制剂
总计46858个结果
-
Novartis Pharmaceuticals终止Non-diabetic Nephropathy荷兰
-
AHEPA University HospitalAristotle University Of Thessaloniki未知
-
Menarini International Operations Luxembourg SA完全的
-
The University of The West IndiesCaribbean Health Research Council未知
-
Istituto Auxologico ItalianoEuropean Society of Hypertension; Chinese Hypertension League完全的
-
Sohag University招聘中血管紧张素转换酶 rs (1799752) 基因多态性与稳定性冠状动脉疾病患者支架内再狭窄的发生埃及
-
Bispebjerg HospitalUniversity of Copenhagen; Duke University; The Ministry of Science, Technology and Innovation,... 和其他合作者完全的
-
Josep M CruzadoWyeth is now a wholly owned subsidiary of Pfizer完全的
-
University of Maryland, BaltimoreKing Pharmaceuticals is now a wholly owned subsidiary of Pfizer终止
-
TSH Biopharm Corporation Limited完全的
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical Sciences完全的
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)完全的
-
Ministry of Health, Labour and Welfare, Japan未知
-
Idorsia Pharmaceuticals Ltd.完全的
-
Paddock Laboratories, Inc.完全的
-
Teva Pharmaceuticals USA完全的
-
Nanfang Hospital of Southern Medical University未知
-
Adil BharuchaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Center for...完全的
-
Ramathibodi HospitalNational Health Security Office, Thailand; Ubon Ratchathani Public Health Office, Thailand; The...未知
-
Forest Laboratories完全的